English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [2438]
News [5427]
Articles [221]
Editorials [8]
Conferences [142]
elearning [14]
ASH 2025: Protective regimen allows successful stem cell transplant even without close genetic match between donor and recipient
ASH 2025: Protective regimen allows successful stem cell transplant even without close genetic match between donor...
ASH 2025: CAR T cell therapy shows promising phase II trial results in multiple myeloma
ASH 2025: CAR T cell therapy shows promising phase II trial results in multiple myeloma
ASH 2025: Study suggests that a virtual programme focusing on diet and exercise can help reduce side effects of lymphoma treatment
ASH 2025: Study suggests that a virtual programme focusing on diet and exercise can help reduce side effects of...
Rebuilding the mind after cancer: a new remote programme offers hope
Rebuilding the mind after cancer: a new remote programme offers hope
New organ-on-a-chip platform allows the testing of cancer vaccine efficacy in ageing populations
New organ-on-a-chip platform allows the testing of cancer vaccine efficacy in ageing populations
Sudden cardiac death risk falls in colorectal cancer, but disparities persist
Sudden cardiac death risk falls in colorectal cancer, but disparities persist
A starting point for the development of new pain and cancer drugs
A starting point for the development of new pain and cancer drugs
From lab to clinic: Phase 1 clinical trial of promising combination therapy for resistant ovarian cancer
From lab to clinic: Phase 1 clinical trial of promising combination therapy for resistant ovarian cancer
Pathway discovered to make the most common breast cancer tumour responsive to immunotherapy
Pathway discovered to make the most common breast cancer tumour responsive to immunotherapy
Researchers suppresses side effects of mRNA therapeutics, broadly applicable platform for safer, personalised treatments​
Researchers suppresses side effects of mRNA therapeutics, broadly applicable platform for safer, personalised...
<12345…543>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top